Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
最新データ
¥2,010
+¥55.00 · +2.81%
日中の時刻はJSTです。市場データは遅延する場合があります。
Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
日中レンジ
現在 ¥2,010
52週レンジ
現在 ¥2,010
日中の時刻はJSTです。市場データは遅延する場合があります。
Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.
日中レンジ
現在 ¥2,010
52週レンジ
現在 ¥2,010
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(JPY) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 1.01兆 JPY | 9973.32億 JPY | 9257.52億 JPY | 8819.23億 JPY | 7501.23億 JPY |
| 売上原価 | 3565.86億 JPY | 3480.45億 JPY | 3421.19億 JPY | 3192.25億 JPY | 2741.31億 JPY |
| 粗利益 | 6540.9億 JPY | 6492.87億 JPY | 5836.33億 JPY | 5626.98億 JPY | 4759.92億 JPY |
| 研究開発 | 1099.48億 JPY | 849.59億 JPY | 807.27億 JPY | 768.66億 JPY | 853億 JPY |
| 販売・一般管理 | 3971.32億 JPY | 3761.8億 JPY | 3512.32億 JPY | 3093.62億 JPY | 2413.34億 JPY |
| 営業費用 | 5070.8億 JPY | 4632.49億 JPY | 4342.96億 JPY | 3862.28億 JPY | 3266.34億 JPY |
| 受取利息 | 61.71億 JPY | 32.95億 JPY | 23.61億 JPY | 37.02億 JPY | 10.13億 JPY |
| 支払利息 | 92.97億 JPY | 48.21億 JPY | 58.09億 JPY | 60.34億 JPY | 51.41億 JPY |
| 減価償却費と償却費 | 672.16億 JPY | 664.56億 JPY | 659.4億 JPY | 667.41億 JPY | 646.15億 JPY |
| 営業利益 | 1470.1億 JPY | 1860.38億 JPY | 1493.37億 JPY | 1764.7億 JPY | 1493.58億 JPY |
| 純利益 | 681.72億 JPY | 1178.55億 JPY | 2425.66億 JPY | 1434.32億 JPY | 1157.42億 JPY |
会社概要が更新されました 2026年10月6日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
Next Funds Nikkei 225 ETF1321.T715.39億0.40%18.93兆 JPY0.08%¥735.1+0.99%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T660.19億0.19%35.83兆 JPY0.05%¥440.4+0.94%
Nikko Exchange Traded Index Fund 2251330.T342.2億0.37%9.24兆 JPY0.08%¥73,780+1.32%
iShares Core Nikkei 225 ETF1329.T84.85億0.37%2.29兆 JPY0.05%¥7,374+1.25%
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T65.94億0.28%2.42兆 JPY0.11%¥37,580+0.27%
iShares Core TOPIX ETF1475.T55.1億0.18%3.04兆 JPY0.05%¥433.8+1.12%
iShares JPX-Nikkei 400 ETF1364.T16.92億0.27%6213.99億 JPY0.05%¥3,878+0.83%
Vanguard Total International Stock ETFVXUS2.06億0.03%6657億 USD0.05%$86.115+0.31%
Next Funds Nikkei 225 ETF1321.T
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
Nikko Exchange Traded Index Fund 2251330.T
iShares Core Nikkei 225 ETF1329.T
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T
iShares Core TOPIX ETF1475.T
iShares JPX-Nikkei 400 ETF1364.T
Vanguard Total International Stock ETFVXUSAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。